Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study completed evaluating the relative bioavailability of Ramipril 10 mg capsules under fasting conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

Sponsor: Sandoz | Conditions: Hypertension | Phase 1 | Status: COMPLETED